HA HUA: Open Payments
NPI 1689158206 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$838 in 38 payments from 11 companies in 2025. Trend: 2023 $138 · 2024 $302 · 2025 $838
Food & beverage: $808Education: $30
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 4 | $203 |
| ABBVIE INC. | 15 | $197 |
| Ipsen Biopharmaceuticals, Inc | 3 | $91 |
| Lilly USA, LLC | 3 | $72 |
| Phathom Pharmaceuticals, Inc. | 4 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $64 |
| PFIZER INC. | 2 | $43 |
| Ardelyx, Inc. | 1 | $29 |
| Celltrion USA Inc. | 1 | $28 |
| QOL Medical, LLC | 1 | $23 |
Products named: REZDIFFRA, IQIRVO, OMVOH, VOQUEZNA, MAVYRET, SKYRIZI, RINVOQ, EOHILIA.
Industry payments across PA — which companies pay providers there.
